Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31764 total
The RealReal heads into its November 3 earnings with short interest stubbornly elevated, insiders having sold in August, and options traders tilting more cautious than they were just weeks ago. Short sellers are not…
CrowdStrike enters the new week with short sellers at their most committed level in months, a BMO analyst raising his target by $60 in a single move, and a CEO selling into every session, all while the stock gave back…
Elanco Animal Health heads into its November 6 earnings with a notable insider buying cluster, modest short rebuilding, and a Street that remains constructively positioned well above the current price. The most…
Champion Homes has shed 5.4% this week to close at $81.03, giving back gains that followed its last earnings beat, with the October 27 print now just 19 days away and the stock sitting 14% below where several analysts…
Scholar Rock Holding Corporation enters the final stretch before its November 11 earnings with a deteriorating price trend, a short position that has grown steadily for six weeks, and a Street that remains broadly…
AIQ, the Global X Artificial Intelligence & Technology ETF, heads into the week with a notable split in its lending market: shares short rose 27% over the past week, yet borrow conditions remain relatively low-cost and…
Ginkgo Bioworks faces its sharpest test of its recent rally. The stock fell 7.6% on Wednesday to $11.47, cutting its one-week loss to 10.6%, even as it retains a 65% gain over the past month. Short sellers have been…
NESR is heading into November earnings with a 32% monthly selloff, a deeply bullish analyst consensus, and a widening gap between what the Street expects and what peers are saying about Middle East activity. The price…
YEXT enters the October stretch with two activist shareholders on its register, a short position that has grown nearly 24% over the past month, and a stock that is up only modestly from where it was a year ago. That…
GDS Holdings heads into its November 13 earnings with an unusual split: short sellers have been quietly covering for weeks, yet the borrow market spent most of September fully exhausted. The covering story is genuine.…
CRSP enters the final stretch before its November 3 earnings date with short sellers adding to an already heavy position and the stock down more than 5% on the week, a combination that frames the next four weeks as a…
VVV heads into its November earnings with short sellers adding exposure, analysts trimming targets, and a stock that has already punished investors badly once this year. The short position tells the most urgent story.…
BATR.K heads into its November 5 earnings with a notable tension: short interest has risen sharply over the past month, options traders are pushing toward their most defensive posture of the year, and three activist…
KSA, the iShares MSCI Saudi Arabia ETF, is carrying one of the most unusual combinations in the ETF space right now: a short position that remains near its highest levels of the year, while options traders have…
Aclaris Therapeutics has turned sharply lower, shedding 35% over the past week and 45% over the past month to close at $3.40, a brutal reversal for a stock that had been up nearly 79% year-to-date as recently as late…
CC enters its November 5 earnings window with short interest holding near a month-long high, a stock still struggling to find footing after a brutal August, and a Street that has spent the past two months doing little…
Babcock & Wilcox sits at an odd intersection this week: nearly 20% of its free float is sold short, yet shares are available to borrow in abundance, cost to borrow is negligible, and an activist with a 25% stake is…
Glaukos Corporation heads into its October 28 earnings report with a contradictory setup: short interest has climbed 12% over the past month, the stock just posted its best daily gain of the quarter, and options…
Zevra Therapeutics heads into its November 9 earnings report with a notable gap between what short sellers are betting and what analysts are saying. Short interest is genuinely elevated at 10.4% of the free float,…
Sunrun heads into its November earnings with a stock down 14% over the past month, a short position covering nearly a third of the float, and Goldman Sachs trimming its target for the third time since August. The most…
